“Safety and Immunogenicity of Ebola Virus and Marburg Virus Glycoprotein DNA Vaccines Assessed Separately and Concomitantly in Healthy Ugandan Adults: A Phase 1b, Randomised, Double-Blind, Placebo-Controlled Clinical Trial”, Lancet, vol. 385, pp. 1545-1554, 2015.
, “Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial”, J Infect Dis, vol. 211, pp. 549-557, 2015.
, “A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.”, Vaccine, vol. 29, no. 2, pp. 304-13, 2010.
, “A Replication Defective Recombinant Ad5 Vaccine Expressing Ebola Virus GP is Safe and Immunogenic in Healthy Adults”, Vaccine, vol. 29, pp. 304-313, 2010.
,